- Novel genetic markers associate with atrial fibrillation risk in europeans and JapaneseSteven A Lubitz
Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston, Massachusetts Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts Electronic address
J Am Coll Cardiol 63:1200-10. 2014..This study sought to identify nonredundant atrial fibrillation (AF) genetic susceptibility signals and examine their cumulative relations with AF risk...
- Personalized medicine and atrial fibrillation: will it ever happen?Steven A Lubitz
Cardiovascular Research Center and Cardiac Arrhythmia Service, Massachusetts General Hospital, 149 13th Street, 4th Floor, Charlestown, MA 02129, USA
BMC Med 10:155. 2012..In this review we explore areas of potential clinical utility in AF management including those relating to pharmacogenetics and risk prediction...
- Comparative performance of gene-based warfarin dosing algorithms in a multiethnic populationS A Lubitz
Zena and Michael Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY, USA
J Thromb Haemost 8:1018-26. 2010..Gene-based warfarin dosing algorithms have largely been developed in homogeneous populations, and their generalizability has not been established...